People understand that diabetes and hypertension are chronic diseases that require long-term drug treatment, but not much is known about the concept that asthma is a chronic airway inflammatory disease that also requires long-term anti-inflammatory and antispasmodic treatment with drugs. In clinical practice, we often encounter some asthma patients with recurrent acute attacks and poorly controlled asthma, the reasons for which are: 1. The use of controlling drugs is not standardized, but only in acute attacks The pharmacological treatment of asthma is divided into two categories, one is the controlling drugs, which are long-term standardized use, with the aim of preventing asthma attacks, and currently commonly used are inhaled glucocorticosteroids (such as pramipexole, bicodone), inhaled glucocorticosteroids plus The other category is relief drugs, also known as emergency drugs, which are used for rapid relief of symptoms when asthma symptoms are present. A patient with asthma should be given a condition assessment based on his symptoms and then given the appropriate level of control medication for long-term treatment with medication to control chronic inflammation of the airways, followed by relief medication when symptoms are present to relieve symptoms. If controlled medications are not used to control the airway inflammation of asthma in general, it will inevitably lead to recurrent acute attacks. 2. Inadequate treatment level The 2006 Global Asthma Control Initiative proposes that the goal of asthma treatment is to achieve and maintain clinical control of asthma. The clinical control of asthma should meet the following 6 items: (1) no (or ≤2 times/week) daytime symptoms; (2) no limitation of daily activities (including exercise); (3) no nocturnal symptoms or awakening due to asthma; (4) no (or ≤2 times/week) need to receive relieving medication; (5) normal or near-normal lung function; (6) no acute exacerbation of asthma. There are five levels of pharmacological treatment for asthma, and the appropriate level of therapeutic drug is given according to the severity of the disease. When that level of treatment does not enable the patient to achieve the goal of clinical control, escalation therapy should be given. For example, if some patients are in serious condition and small doses of inhaled glucocorticosteroids alone cannot make him achieve asthma control, inhaled glucocorticosteroids plus long-acting β2 agonists (sulforaphane or sinequan), or cisplatin should be added, or the inhaled hormone dose should be increased to make him achieve asthma control as soon as possible. 3.Control medication discontinued too early Some asthma patients discontinue their medication once their symptoms improve and their condition is controlled, and then have asthma attacks soon after discontinuation. The goal of asthma treatment is not only to achieve but also to maintain asthma control, and to meet the six composite indicators. If the anti-inflammatory therapy treatment time is insufficient and the airway inflammation is not well controlled, premature discontinuation of medication can lead to acute asthma attacks. 4, inhalation of drugs in the wrong way The route of administration of asthma is based on inhalation of drugs, which needs to be equipped with certain devices and master the correct inhalation method. We often encounter some patients who do not know how to use the inhalation medication, or although they are using it, but the method is incorrect, resulting in the inhalation medication does not play the proper efficacy. Therefore, patients must learn the correct inhalation method when using inhalation drugs for the first time, and physicians should automatically teach patients how to use inhalation drugs when they are prescribed. The majority of patients with asthma can achieve and maintain clinical control of their asthma as long as they are given standardized treatment, adhere to the correct medication, and avoid these conditions.